Biocon receives CRL from US FDA over cancer treatment biosimilar
The biosimilar Pegfilgrastim is indicated for use in treatment of cancer, jointly developed by Biocon and Mylan
Biotechnology…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pfizer reviewing alternatives for consumer healthcare business
The company will be considering a range of options including a full or partial separation of the business through a spin-off, sale…
Pharma city to attract investment worth Rs 64,000 cr
According to KT Rama Rao, Industries Minister, Telangana, the project is expected to generate employment to 4.2 lakh people…
Lupin to acquire Symbiomix Therapeutics
The acquisition expands Lupin’s branded women’s health speciality business
Regenerative medicine set to shake up therapy market
Regenerative medicine could produce new therapeutic interventions for cancers, genetic disorders or autoimmune diseases
Clariant launches packaging solutions for probiotics
The shelf life of probiotics in nutraceutical products is extended by inhibiting their exposure to damaging oxygen, moisture and…
Pharma exports declined by 4 per cent up to Aug on pricing pressure
Udaya Bhaskar, Director General, Pharmexcil hopes that the overall exports will recover and come into positive zone for the full…
PPS to expand API manufacturing capabilities in Asia and North America
Announces investments worth $55 million
Vice President inaugurates third International Conference on Yoga
The theme of this year’s conference will be ‘Yoga for Wellness’
Vice President, M Venkaiah Naidu inaugurated the two-day…